BR112013004202A2 - cacacterizacão celular - Google Patents
cacacterizacão celularInfo
- Publication number
- BR112013004202A2 BR112013004202A2 BR112013004202A BR112013004202A BR112013004202A2 BR 112013004202 A2 BR112013004202 A2 BR 112013004202A2 BR 112013004202 A BR112013004202 A BR 112013004202A BR 112013004202 A BR112013004202 A BR 112013004202A BR 112013004202 A2 BR112013004202 A2 BR 112013004202A2
- Authority
- BR
- Brazil
- Prior art keywords
- cellular characterization
- characterization
- cellular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1014049.9A GB201014049D0 (en) | 2010-08-23 | 2010-08-23 | Cell characterisation |
| PCT/GB2011/001241 WO2012025709A1 (en) | 2010-08-23 | 2011-08-19 | Cell characterisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013004202A2 true BR112013004202A2 (pt) | 2019-09-24 |
Family
ID=42984495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013004202A BR112013004202A2 (pt) | 2010-08-23 | 2011-08-19 | cacacterizacão celular |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US20130196875A1 (https=) |
| EP (1) | EP2609217B1 (https=) |
| JP (1) | JP2013535979A (https=) |
| KR (1) | KR20140006775A (https=) |
| CN (1) | CN103403180A (https=) |
| AU (1) | AU2011294936A1 (https=) |
| BR (1) | BR112013004202A2 (https=) |
| CA (1) | CA2847151C (https=) |
| GB (1) | GB201014049D0 (https=) |
| IL (1) | IL224888B (https=) |
| SG (2) | SG190837A1 (https=) |
| WO (1) | WO2012025709A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2859119A2 (en) * | 2012-06-12 | 2015-04-15 | Institute for Systems Biology | Complex rna composition of bodily fluids |
| US11293065B2 (en) | 2016-03-14 | 2022-04-05 | Aelan Cell Technologies, Inc. | Compositions and methods for the quality control of stem cell preparations |
| CA3062963A1 (en) * | 2016-05-09 | 2017-11-16 | Sistemic Scotland Ltd | Functional prediction of cellular functions by means of microrna expression profiling in mesenchymal stem cells |
| JP6629770B2 (ja) * | 2017-01-19 | 2020-01-15 | シスメックス株式会社 | 細胞の分化状態を評価する方法 |
| JP6918062B2 (ja) * | 2017-01-19 | 2021-08-11 | シスメックス株式会社 | 細胞の分化状態を評価する方法 |
| WO2019141878A1 (en) * | 2018-01-22 | 2019-07-25 | Sistemic Scotland Ltd | Cell contamination assay |
| WO2020072545A1 (en) * | 2018-10-01 | 2020-04-09 | Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center | MicroRNA TRANSCRIPTIONAL SIGNATURE (miR-TS) EVALUATION OF STEM CELLS |
| CN113658636B (zh) * | 2021-07-22 | 2025-08-05 | 未来智人再生医学研究院(广州)有限公司 | 一种评估多能干细胞质量的方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050123952A1 (en) * | 2003-09-04 | 2005-06-09 | Griffey Richard H. | Methods of rapid detection and identification of bioagents using microRNA |
| CA2566519C (en) * | 2004-05-14 | 2020-04-21 | Rosetta Genomics Ltd. | Micrornas and uses thereof |
| EP1966390A1 (en) * | 2005-12-29 | 2008-09-10 | Exiqon A/S | Detection of tissue origin of cancer |
| CN101316935B (zh) * | 2006-11-28 | 2012-02-29 | 博奥生物有限公司 | 一种用于诊断食道癌的芯片 |
| WO2008073915A2 (en) * | 2006-12-08 | 2008-06-19 | Asuragen, Inc. | Micrornas differentially expressed in leukemia and uses thereof |
| WO2008112283A2 (en) * | 2007-03-12 | 2008-09-18 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Microrna profiling of androgen responsiveness for predicting the appropriate prostate cancer treatment |
| US8361714B2 (en) * | 2007-09-14 | 2013-01-29 | Asuragen, Inc. | Micrornas differentially expressed in cervical cancer and uses thereof |
| WO2009062503A1 (en) * | 2007-11-14 | 2009-05-22 | Dandrit Biotech A/S | Micro rnas as markers of the functional state of a dendritic cell |
| JP2011516033A (ja) * | 2008-02-28 | 2011-05-26 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 急性骨髄性性白血病（ａｍｌ）における細胞遺伝学および予後と関連するマイクロｒｎａシグネチャーおよびその使用 |
| US20100003674A1 (en) * | 2008-07-03 | 2010-01-07 | Cope Frederick O | Adult stem cells, molecular signatures, and applications in the evaluation, diagnosis, and therapy of mammalian conditions |
| EP2387617B1 (en) * | 2009-01-19 | 2014-10-29 | Sistemic Scotland Limited | Methods employing non-coding rna expression assays |
-
2010
- 2010-08-23 GB GBGB1014049.9A patent/GB201014049D0/en not_active Ceased
-
2011
- 2011-08-19 CA CA2847151A patent/CA2847151C/en active Active
- 2011-08-19 BR BR112013004202A patent/BR112013004202A2/pt not_active IP Right Cessation
- 2011-08-19 US US13/818,750 patent/US20130196875A1/en not_active Abandoned
- 2011-08-19 AU AU2011294936A patent/AU2011294936A1/en not_active Abandoned
- 2011-08-19 CN CN2011800509567A patent/CN103403180A/zh active Pending
- 2011-08-19 EP EP11760806.7A patent/EP2609217B1/en active Active
- 2011-08-19 SG SG2013038724A patent/SG190837A1/en unknown
- 2011-08-19 KR KR1020137007313A patent/KR20140006775A/ko not_active Ceased
- 2011-08-19 WO PCT/GB2011/001241 patent/WO2012025709A1/en not_active Ceased
- 2011-08-19 SG SG10201506595QA patent/SG10201506595QA/en unknown
- 2011-08-19 JP JP2013525347A patent/JP2013535979A/ja active Pending
-
2013
- 2013-02-24 IL IL224888A patent/IL224888B/en active IP Right Grant
-
2016
- 2016-08-22 US US15/243,202 patent/US20170218446A1/en not_active Abandoned
-
2019
- 2019-08-26 US US16/551,337 patent/US20200080148A1/en not_active Abandoned
-
2022
- 2022-12-13 US US18/079,922 patent/US20230183803A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL224888B (en) | 2020-10-29 |
| EP2609217B1 (en) | 2019-03-27 |
| AU2011294936A1 (en) | 2013-04-11 |
| SG10201506595QA (en) | 2015-10-29 |
| CA2847151C (en) | 2023-11-28 |
| CN103403180A (zh) | 2013-11-20 |
| JP2013535979A (ja) | 2013-09-19 |
| KR20140006775A (ko) | 2014-01-16 |
| GB201014049D0 (en) | 2010-10-06 |
| US20200080148A1 (en) | 2020-03-12 |
| EP2609217A1 (en) | 2013-07-03 |
| US20230183803A1 (en) | 2023-06-15 |
| US20130196875A1 (en) | 2013-08-01 |
| SG190837A1 (en) | 2013-07-31 |
| WO2012025709A1 (en) | 2012-03-01 |
| CA2847151A1 (en) | 2012-03-01 |
| US20170218446A1 (en) | 2017-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013014486A2 (pt) | amortecimento celular interpontualizado | |
| DK2646647T3 (da) | Frakturkarakterisering | |
| DK3053932T3 (da) | Hidtil ukendte ctla4-ig-immunoadhesiner | |
| DK2536830T3 (da) | Polypeptider | |
| IL226437A0 (en) | Dosage form | |
| UA21667S (uk) | Телефон мобільний | |
| EP2661055A4 (en) | MOBILE PHONE | |
| EP2681855A4 (en) | RADIO TEST | |
| IL225897B (en) | Cxcr2 binding polypeptides | |
| FI20105284L (fi) | Sekoitin | |
| EP2551283A4 (en) | ANTIALLERGENIC ACTIVE SUBSTANCE | |
| EP2730040A4 (en) | RADIO TRANSMISSION TEST | |
| EP2579281A4 (en) | REACTOR | |
| EP2396853A4 (en) | ANTENNA | |
| EP2571756A4 (en) | RADOM | |
| EP2613447A4 (en) | MOBILE TERMINAL | |
| ES2609638T8 (es) | Poración celular | |
| DK3372070T3 (da) | Pattekop-gummi | |
| FI20095085A0 (fi) | Moniresonanssiantenni | |
| BR112013004202A2 (pt) | cacacterizacão celular | |
| ES1078048Y (es) | Proyector de celular | |
| FI20095830A0 (fi) | Tukivaljaat | |
| FI20086252A0 (fi) | Radiovastaanotin | |
| EP2623103A4 (en) | PLASTER | |
| EP2451006A4 (en) | PORTABLE RADIO |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |